Medically Speaking: Melanoma

Published Online: Wednesday, September 26, 2012
Follow Pharmacy_Times:
In this podcast, Susan Kesmodel, MD, of the University of Maryland Marlene and Stewart Greenebaum Cancer Center in Baltimore, discusses diagnosis, treatment, and prevention of melanoma.
 
To listen to this podcast, click here.
Related Articles
A combination of vemurafenib (Zelboraf) and experimental drug cobimetinib significantly reduces the development of secondary skin cancer.
The results of an FDA safety review of omalizumab (Xolair) suggest the asthma drug slightly elevates the risk of serious cardiovascular and cerebrovascular adverse events.
RX-3117 maintains anti-tumor activity in cancer cell lines that are resistant to gemcitabine.
Latest Issues
$auto_registration$